Phenomex stock.

Berkeley Lights (Nasdaq: BLI), a life sciences tools company, and IsoPlexis (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million.WHEREAS, on the terms and subject to the conditions set forth in this Agreement, Merger Sub has agreed to commence (within the meaning of Rule 14d-2 under the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (the “Exchange Act”)), a cash tender offer to acquire any and all of the outstanding shares of the Company Common Stock for $1.00 per ...PhenomeX to begin trading under symbol (NASDAQ: CELL) EMERYVILLE, Calif., March 21, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of Isoplexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the …Item 7.01. Regulation FD Disclosure. Berkeley Lights, Inc. is aware of certain well-publicized recent developments involving Silicon Valley Bank . The Company considers its own banking exposure to... | May 2, 202365.18. -0.58. -0.89%. BILLERICA, Mass. & EMERYVILLE, Calif., August 17, 2023--Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) today …Web

The fair value is based on 24,945,611 shares of PhenomeX common stock at $1.28 per share on March 21, 2023 issued to IsoPlexis stockholders. IsoPlexis stockholders received 0.612 shares of PhenomeX stock for each IsoPlexis share they held.Bird Mergersub Corporation, a Delaware corporation (“Purchaser”) and a wholly owned subsidiary of Bruker Corporation, a Delaware corporation (“Bruker”), is offering to purchase all of the outstanding shares of common stock, par value $0.00005 per share (the “Shares”), of PhenomeX Inc., a Delaware corporation (“PhenomeX”), for $1.00 per Share, net to …

PhenomeX Inc. CELL stock has more than doubled on Thursday after Bruker Corp. BRKR, +1.49% said it would acquire the Emeryville, Calif.-based, cell biology company for $1 a share in a deal that ...Jun. 28, 2023 at 9:41 a.m. ET on Baystreet.ca. CELL | Complete Grid Battery Metals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full …Web

66.06. +0.97. +1.49%. BILLERICA, Mass., October 03, 2023--Bruker Corporation (Nasdaq: BRKR) today announced that it has completed the acquisition of …WebSep 20, 2023 · For PhenomeX (Nasdaq: CELL), 2023 has been a wild ride. Following the merger of Berkeley Lights and IsoPlexis on March 21, 2023, PhenomeX was formed. As a result of this merger, The Beacon ... EMERYVILLE, Calif., Nov. 18, 2020 -- Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the pricing of its previously announced public offering of 3,000,000 shares of common... | March 27, 2023PhenomeX is selling for 0.9399 as of the 21st of August 2023. This is a -1.06 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.94.PhenomeX has a very small chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. PhenomeX …

Preliminary SpotLight™ Human Lambda reagent data to be showcased by GSK at the 16 th annual PEACe Conference. EMERYVILLE, Calif., Sept. 21, 2023 /PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), a ...

PhenomeX Inc., formerly Berkeley Lights, Inc., is a functional cell biology company. The Company enables scientists to leverage each cell and drive the next generation of functional cell biology that will advance human health.

377.43. -0.11%. 9.38M. View today's Phenomex Inc stock price and latest CELL news and analysis. Create real-time notifications to follow any changes in the live stock price.WebUnder the Warrant Certificate, the outstanding warrant (the “ IsoPlexis Warrant ”) to purchase shares of common stock, par value $0.001, of IsoPlexis (“ IsoPlexis Common Stock ”), issued by IsoPlexis to Perceptive was assumed by PhenomeX and converted into a warrant (the “ PhenomeX Warrant ”) to purchase shares of common stock, par ...Bruker Cellular Analysis is uniquely enabling the exploration of the phenome and mastery of single cells for all labs & scientists through a simple and accessible workflow.Webull offers Phenomex stock information, including NASDAQ: CELL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, …WebMay 11, 2023 · EMERYVILLE, Calif., May 11, 2023 /PRNewswire/ -- PhenomeX (Nasdaq: CELL), the functional cell biology company, today announced that it will participate in the 19 th annual Protein Engineering ... Item 1.02 Termination of a Material Definitive Agreement. On June 30, 2023, PhenomeX Inc. (the "Company") repaid in full all outstanding indebtedness under the Second Amended and Restated Loan and Security Agreement (the "PhenomeX Credit Agreement "), dated as of March 21, 2023, among, inter alios, Company, IsoPlexis Corporation, a Delaware corporation and East West Bank, a California banking ...Bruker Corporation (NasdaqGS:BRKR) signed a definitive agreement to acquire all of the outstanding shares of PhenomeX Inc. (NasdaqGS:CELL). Aug. 16. CI. Berenberg Bank Adjusts PhenomeX Price Target to $8 From $9, Maintains Buy Rating. Aug. 15. MT. Earnings Flash (CELL) PHENOMEX Posts Q2 Revenue $14.1M, vs. Street Est of $17.4M. Aug. 14.

The fair value is based on 24,945,611 shares of PhenomeX common stock at $ 1.28 per share on March 21, 2023 issued to IsoPlexis stockholders. IsoPlexis stockholders received 0.612 shares of PhenomeX stock for …Oct 3, 2023 · As a result of the transaction closing, PhenomeX common stock will no longer be listed for trading on the Nasdaq Global Market. Also, PhenomeX will soon be changing its name. Bruker Corporation (NasdaqGS:BRKR) signed a definitive agreement to acquire all of the outstanding shares of PhenomeX Inc. (NasdaqGS:CELL). Aug. 16. CI. Berenberg Bank Adjusts PhenomeX Price Target to $8 From $9, Maintains Buy Rating. Aug. 15. MT. Earnings Flash (CELL) PHENOMEX Posts Q2 Revenue $14.1M, vs. Street Est of $17.4M. Aug. 14.Bird Mergersub Corporation, a Delaware corporation (“Purchaser”) and a wholly owned subsidiary of Bruker Corporation, a Delaware corporation (“Bruker”), is offering to purchase all of the outstanding shares of common stock, par value $0.00005 per share (the “Shares”), of PhenomeX Inc., a Delaware corporation (“PhenomeX”), for $1.00 per Share, net to the seller in cash, without ... Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.Historical daily share price chart and data for PhenomeX Inc. from 2020 to 2023 adjusted for splits and dividends. CELL was delisted after September 29, 2023. The latest closing stock price for PhenomeX Inc. on September 29, 2023 is 1.00. The all-time high PhenomeX Inc. closing stock price was 106.00 on December 22, 2020. Company profile page for Phenomenex Inc including stock price, company news, press releases, executives, board members, and contact information

May 11, 2023 · EMERYVILLE, Calif., May 11, 2023 /PRNewswire/ -- PhenomeX (Nasdaq: CELL), the functional cell biology company, today announced that it will participate in the 19 th annual Protein Engineering ...

PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business Update PR Newswire - Mon Aug 14, 3:05PM CDT /PRNewswire/ -- PhenomeX, Inc. (Nasdaq: …WebPhenomeX stock rallies by 137% after buyout offer from Bruker PhenomeX Inc. CELL, +137.43% stock has more than doubled on Thursday after Bruker Corp. …WebMar 21, 2023 · PhenomeX (Nasdaq: CELL), the functional cell biology company, today announced that Yan Zhang, Ph.D., has been named chief commercial officer (CCO), effective immediately. In addition to Dr. Zhang ... Recent Highlights. Achieved total revenue of $18.5 million for the first quarter 2023, including: $11.3 million in platform and recurring revenue, including $1.0 million in revenue from IsoPlexis following the closing of the acquisition on March 21, 2023; 8 platform placements, bringing the PhenomeX installed base to 430 platforms; and.29 sept 2023 ... outstanding shares of common stock, par value $0.00005 per share (the “Shares”), of PhenomeX Inc., a Delaware corporation (“PhenomeX”), for ...3 oct 2023 ... As a result of the transaction closing, PhenomeX common stock will no longer be listed for trading on the Nasdaq Global Market. Also, PhenomeX ...PhenomeX stock rallies by 137% after buyout offer from Bruker PhenomeX Inc. CELL, +137.43% stock has more than doubled on Thursday after Bruker Corp. …WebWhen it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.Mar 22, 2023 · The newly combined company has been renamed PhenomeX and its common stock will begin trading on Nasdaq under the ticker symbol ... PhenomeX will have a global commercial footprint with more than ...

PhenomeX Inc. CELL stock has more than doubled on Thursday after Bruker Corp. BRKR, +1.49% said it would acquire the Emeryville, Calif.-based, cell biology company for $1 a share in a deal that...

Discover historical prices for CELL stock on Yahoo Finance. View daily, weekly or monthly format back to when PhenomeX Inc. stock was issued.

ZebronZB-5MS PLUS. Better Peak Shape, Low Bleed, and Aqueous Stability for specialty chemical, forensic, toxicology, and food testing applications. Leading Manufacturer of HPLC Columns, GC columns, Sample Prep Products, and …BETR. Better Home & Finance Holding Company Class A Common Stock. $1.56 +0.41 +35.65%. Find the latest SEC Filings data for PhenomeX Inc. Common Stock (CELL) at Nasdaq.com.Real time PhenomeX (BLI) stock price quote, stock graph, news & analysis. Dec 22, 2022 · Berkeley Lights (Nasdaq: BLI), a life sciences tools company, and IsoPlexis (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million. -- Health care stocks extended their Wednesday gains, with the NYSE Health Care Index rising 2.5% this afternoon while the SPDR Health Care Select Sector ETF was up 2.1%. The Nasdaq Biotechnology... | May 11, 2023Sep 5, 2023 · Story continues PhenomeX Inc. (Nasdaq: CELL) today announced that Bruker Corporation (Nasdaq: BRKR) has commenced, through its wholly owned subsidiary, Bird Mergersub Corporation, a cash tender... PhenomeX (Nasdaq: CELL), the functional cell biology company, ... There's a new set of eight S&P 500 stocks taking off in the ongoing eight-day rally. 2d ago. The Wall Street Journal.All Outstanding Shares of Common Stock . of . PHENOMEX INC. at $1.00 per share, net in cash, without interest . Pursuant to the Offer to Purchase dated August 31, 2023 . by . BIRD MERGERSUB CORPORATION . a wholly-owned subsidiary . of . BRUKER CORPORATIONCompany profile page for PhenomeX Inc including stock price, company news, press releases, executives, board members, and contact information CELL | Complete Grid Battery Metals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Historical daily share price chart and data for PhenomeX Inc. from 2020 to 2023 adjusted for splits and dividends. CELL was delisted after September 29, 2023. The latest closing …WebAug 31, 2023 · All Outstanding Shares of Common Stock . of . PHENOMEX INC. at $1.00 per share, net in cash, without interest . Pursuant to the Offer to Purchase dated August 31, 2023 . by . BIRD MERGERSUB CORPORATION . a wholly-owned subsidiary . of . BRUKER CORPORATION

CELL | Complete Grid Battery Metals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.3. The Offer is being made pursuant to an Agreement and Plan of Merger, dated August 17, 2023 (as it may be amended from time to time, the “Merger Agreement”), by and among PhenomeX, Bruker and Purchaser, pursuant to which, after consummation of the Offer and the satisfaction or waiver of certain conditions, Purchaser will merge with …Return on Assets (ROA) of PhenomeX 2023 is 0. In 2023, PhenomeX's return on assets (ROA) was 0, a 0% increase from the 0 ROA in the previous year..BILLERICA, Mass., October 03, 2023--Bruker Corporation (Nasdaq: BRKR) today announced that it has completed the acquisition of PhenomeX, a leading provider of single-cell biology research tools,...Instagram:https://instagram. anheiser busch stockstesla earninin stock alert app3x short tesla etf Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.Financing. Details. PhenomeX Inc is a functional cell biology company that provides live cell biology research tools which deliver deep insi. Drug Discovery. Emeryville, CA. 285 As of 2022. 00000. 0000 0000-00-00. moat holdings110 washington bloomfield PhenomeX Description. PhenomeX Inc. operates as a functional cell biology company. The company enables scientists to reveal insights on cell function and obtain behavior of each cell. Its suite of tools and services offer unparalleled resolution and speed, accelerating the insights for advancing discoveries that can profoundly improve the ... how to get into crypto trading During its Q3 2023 earnings release, Bruker will provide more details on the expected Q4 2023 effect from PhenomeX. Today, Bruker reconfirms its medium-term financial outlook as issued at its Investor Day in June 2023. As a result of the transaction closing, PhenomeX common stock will no longer be listed for trading on the Nasdaq Global Market.PhenomeX was formed earlier this year when cell analysis firm Berkeley Lights closed its acquisition of proteomics firm IsoPlexis for $57.8 million in stock. In Q1, the firm reported revenues of $18.5 million, down 8 percent year over year.